Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era ; volume:21 ; number:1 ; day:8 ; month:7 ; year:2019 ; pages:1-10 ; date:12.2019
Arthritis Research & Therapy ; 21, Heft 1 (8.7.2019), 1-10, 12.2019
- Urheber
-
Giancane, Gabriella
Muratore, Valentina
Marzetti, Valentina
Quilis, Neus
Benavente, Belen Serrano
Bagnasco, Francesca
Alongi, Alessandra
Civino, Adele
Quartulli, Lorenzo
Consolaro, Alessandro
Ravelli, Angelo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-019-1950-7
- URN
-
urn:nbn:de:101:1-2019110521083531397401
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Giancane, Gabriella
- Muratore, Valentina
- Marzetti, Valentina
- Quilis, Neus
- Benavente, Belen Serrano
- Bagnasco, Francesca
- Alongi, Alessandra
- Civino, Adele
- Quartulli, Lorenzo
- Consolaro, Alessandro
- Ravelli, Angelo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Predictors of response to methotrexate in juvenile idiopathic arthritis
The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Impaired cardiorespiratory and neuromuscular fitness in children and adolescents with juvenile idiopathic arthritis: a cross-sectional case–control study in the era of biologic drug therapies
Biologic agents in juvenile spondyloarthropathies
Predictors of response to methotrexate in juvenile idiopathic arthritis
The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Impaired cardiorespiratory and neuromuscular fitness in children and adolescents with juvenile idiopathic arthritis: a cross-sectional case–control study in the era of biologic drug therapies
Biologic agents in juvenile spondyloarthropathies
Predictors of response to methotrexate in juvenile idiopathic arthritis
The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Impaired cardiorespiratory and neuromuscular fitness in children and adolescents with juvenile idiopathic arthritis: a cross-sectional case–control study in the era of biologic drug therapies